A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
Jackson CG, Moore KN, Cantrell L, Erickson BK, Duska LR, Richardson DL, Landrum LM, Holman LL, Walker JL, Mannel RS, Moxley KM, Queimado L, Cohoon A, Ding K, Dockery LE.
Jackson CG, et al. Among authors: dockery le.
Gynecol Oncol. 2022 Jul;166(1):44-49. doi: 10.1016/j.ygyno.2022.04.016. Epub 2022 Apr 28.
Gynecol Oncol. 2022.
PMID: 35491267
Free PMC article.
Clinical Trial.